Interaksi Fentanil dan Lemboreksant

Fentanil dan Lemboreksant: kedua label peresepan menandai kombinasi ini dengan bahasa yang paling tegas, seperti kontraindikasi, peringatan kotak hitam, atau instruksi untuk menghindarinya.

Mayor

Jangan dikombinasikan tanpa arahan dokter yang meresepkan. Bahasa label di bawah ini adalah yang paling tegas yang digunakan FDA.

Apa kata label FDA

Dari label Fentanil (FENTANYL CITRATE) · berlaku sejak 2026-04-07

Mayor

• Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death.

Peringatan kotak hitamberdasarkan golongan obatLihat label di DailyMed
Mayor

Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death.

Peringatan kotak hitamberdasarkan golongan obatLihat label di DailyMed
Mayor

Reserve concomitant prescribing of Fentanyl Citrate Injection and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate [see Warnings and Precautions (5.3) , Drug Interactions (7) ] .

Peringatan kotak hitamberdasarkan golongan obatLihat label di DailyMed
Mayor

Profound sedation, respiratory depression, coma, and death may result from the concomitant use of Fentanyl Citrate Injection with benzodiazepines and/or other CNS depressants, including alcohol (e.g., non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, gabapentinoids [gabapentin or pregabalin],…

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Risks from Concomitant Use with Benzodiazepines or Other Central Nervous System Depressants When benzodiazepines or other CNS depressants are used with Fentanyl Citrate Injection, pulmonary arterial pressure may be decreased.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed

Dari label Lemboreksant (DAYVIGO) · berlaku sejak 2025-02-24

Moderat

CNS Depressant Effects and Daytime Impairment: Impairs alertness and motor coordination including morning impairment.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Risk increases with dose and use with other central nervous system (CNS) depressants.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Co-administration with other CNS depressants (e.g., benzodiazepines, opioids, tricyclic antidepressants, alcohol) increases the risk of CNS depression, which can cause daytime impairment.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

Dosage adjustments of DAYVIGO and of concomitant CNS depressants may be necessary when administered together because of potentially additive effects.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Minor

CNS Depressant Effects and Daytime Impairment DAYVIGO is a central nervous system (CNS) depressant that can impair daytime wakefulness even when used as prescribed.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed

Menggunakan lebih dari dua obat ini? Interaksi saling bertumpuk. Periksa seluruh daftar Anda sekaligus; daftar itu tetap berada di peramban Anda.

Buka di pemeriksa

Bukan nasihat medis. Interaction Checker mengutip teks label FDA dan lembar fakta NIH. Penting atau tidaknya suatu interaksi bagi Anda bergantung pada dosis, waktu penggunaan, fungsi ginjal dan hati, serta kondisi lain. Pastikan dengan apoteker atau dokter yang meresepkan.